MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
72.62
-2.21
-2.95%
After Hours: 72.62 0 0.00% 19:30 09/29 EDT
OPEN
74.14
PREV CLOSE
74.83
HIGH
74.78
LOW
72.47
VOLUME
328.84K
TURNOVER
--
52 WEEK HIGH
97.00
52 WEEK LOW
69.58
MARKET CAP
1.67B
P/E (TTM)
15.75
1D
5D
1M
3M
1Y
5Y
1D
3 Profitable Stocks Worth Investigating
Barchart · 1d ago
Weekly Report: what happened at ANIP last week (0921-0925)?
Weekly Report · 1d ago
ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build
Seeking Alpha · 5d ago
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
Barchart · 6d ago
ANI Pharmaceuticals Price Target Announced at $85.00/Share by Oppenheimer
Dow Jones · 6d ago
Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85
Benzinga · 6d ago
ANI Pharmaceuticals Wins FDA Approval For Generic Everolimus Tablets For Oral Suspension
NASDAQ · 6d ago
FDA Approves ANI Pharma's Generic Everolimus Tablets
NASDAQ · 6d ago
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units, Rare Disease and Brands. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel and ILUVIEN. The Brands unit includes a portfolio of over 20 branded products that are principally sold in genericized markets. Its Generics and Other segment consists of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.